Evidence map›Paper›PMID 39200051›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Targeting

Janja Sluga, Tihomir Tomašič, Marko Anderluh, Martina Hrast Rambaher, Gregor Bajc, Alen Sevšek, Nathaniel I Martin, Roland J Pieters, Marjana Novič, Katja Venko

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Frontiers in microbiology · 2026
    Article
  2. A rational approach to discovering new persister control agents.Antimicrobial agents and chemotherapy · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Janja SlugaLaboratory for Cheminformatics, Theory Department, National Institute of Chemistry, Hajdrihova ulica 19, 1000 Ljubljana, Slovenia.
Tihomir TomašičDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5534-209X
Marko AnderluhDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1768-8246
Martina Hrast RambaherDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.
Gregor BajcDepartment of Biology, Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 111, 1000 Ljubljana, Slovenia.
Alen SevšekDepartment of Chemical Biology & Drug Discovery, Utrecht University, Universiteitsweg 99, 3584 Utrecht, The Netherlands.
Nathaniel I MartinDepartment of Chemical Biology & Drug Discovery, Utrecht University, Universiteitsweg 99, 3584 Utrecht, The Netherlands.
Roland J PietersDepartment of Chemical Biology & Drug Discovery, Utrecht University, Universiteitsweg 99, 3584 Utrecht, The Netherlands.ORCID 0000-0003-4723-3584
Marjana NovičLaboratory for Cheminformatics, Theory Department, National Institute of Chemistry, Hajdrihova ulica 19, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4243-2181
Katja VenkoLaboratory for Cheminformatics, Theory Department, National Institute of Chemistry, Hajdrihova ulica 19, 1000 Ljubljana, Slovenia.ORCID 0000-0002-7838-234X

Funding

National Institute of Chemistry 39008Slovenian Research Agency P1-0017
6 · The paper itself

Abstract

Bacteria are capable of remarkable adaptations to their environment, including undesirable bacterial resistance to antibacterial agents. One of the most serious cases is an infection caused by multidrug-resistant

Indexed as

autolysin Eenzyme inhibitionglycoside hydrolaseiminosugarssurface plasmon resonance

Identifiers

PMID39200051
PMCPMC11350809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.